FLEE - ETF AI Analysis
Top Page
Franklin FTSE Europe ETF (FLEE)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, showing positive momentum for investors.
Leading European Blue-Chip Holdings
Top positions like ASML, HSBC, Novartis, Nestlé, Shell, Siemens, Santander, and Allianz have generally shown strong or steady performance, supporting the fund’s returns.
Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Regional Concentration in Europe
The ETF is heavily focused on European markets, which means performance is closely tied to economic and political conditions in that region.
Mixed Performance Among Top Holdings
While many top holdings are doing well, some like AstraZeneca have shown weaker performance, which can drag on overall results.
Moderate Fund Size
With a relatively modest asset base, the ETF may be less liquid than larger funds, which could lead to slightly wider trading spreads for investors.
FLEE vs. SPDR S&P 500 ETF (SPY)
AUM116.35M
RegionEurope
Expense Ratio0.09%
Beta0.73
IssuerFranklin
Inception DateNov 02, 2017
Dividend Yield3.14%
Asset ClassEquity
Index TrackedFTSE Developed Europe RIC Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,209
30 Day Avg. Volume12,454
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.98Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering485
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLEE Summary
Franklin FTSE Europe ETF (FLEE) is an exchange-traded fund that follows the FTSE Developed Europe Index, giving you broad exposure to major stock markets across Europe, including the UK, France, Germany, and Switzerland. It owns many types of companies across different industries, such as ASML, Nestlé, HSBC, and Novartis, so you’re not tied to just one sector. Someone might invest in FLEE to add international diversification and long-term growth potential to a portfolio without having to pick individual European stocks. A key risk is that its value can rise or fall with European stock markets and currency movements.
How much will it cost me?The Franklin FTSE Europe ETF (Ticker: FLEE) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed ETF that tracks the FTSE Developed Europe Index, keeping costs down.
What would affect this ETF?The Franklin FTSE Europe ETF (FLEE) could benefit from economic recovery in Europe, increased industrial activity, and growth in healthcare and technology sectors, which are among its top exposures. However, it may face challenges from rising interest rates, geopolitical tensions, or regulatory changes that could impact key holdings like ASML, SAP, and Nestlé, as well as broader European markets. Investors should also consider potential currency fluctuations that might affect returns from this Europe-focused ETF.
FLEE Top 10 Holdings
FLEE leans heavily into Europe’s blue-chip story, with ASML acting as the star performer, its rising share price giving the fund a strong tech tailwind despite overall low tech weight. Financials like HSBC and Banco Santander are also climbing, helping anchor returns from the banking side. Health care is a major pillar: Roche and Novartis are steady to rising, but AstraZeneca is losing steam and slightly holding the fund back. Nestlé’s mixed, defensive profile adds stability, while Siemens’ solid, rising performance rounds out this developed Europe-focused mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.51% | $5.27M | €564.73B | 114.32% | 76 Outperform | |
| HSBC Holdings | 2.45% | $2.87M | £266.42B | 54.18% | 80 Outperform | |
| Roche Holding AG | 2.02% | $2.36M | $336.17B | 30.34% | 73 Outperform | |
| Shell (UK) | 1.91% | $2.23M | £203.38B | 34.66% | 73 Outperform | |
| Novartis AG | 1.74% | $2.04M | CHF205.09B | 13.34% | 80 Outperform | |
| Nestlé SA | 1.66% | $1.95M | CHF199.45B | 2.49% | 71 Outperform | |
| AstraZeneca | 1.62% | $1.89M | $245.44B | -0.73% | 80 Outperform | |
| Siemens | 1.53% | $1.79M | €201.73B | 16.09% | 74 Outperform | |
| Banco Santander | 1.51% | $1.76M | €193.34B | 51.58% | 73 Outperform | |
| SAP SE | 1.44% | $1.69M | €206.96B | -19.68% | 66 Neutral |
FLEE Technical Analysis
Neutral
―
Price Trends
39.42
Negative
38.67
Positive
37.59
Positive
Market Momentum
-0.18
Positive
36.18
Neutral
16.59
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLEE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 39.73, equal to the 50-day MA of 39.42, and equal to the 200-day MA of 37.59, indicating a neutral trend. The MACD of -0.18 indicates Positive momentum. The RSI at 36.18 is Neutral, neither overbought nor oversold. The STOCH value of 16.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FLEE.
FLEE Peer Comparison
Comparison Results
Performance Comparison
FLEE
Franklin FTSE Europe ETF
38.72
5.13
15.27%
VGK
Vanguard FTSE Europe ETF
―
―
―
EZU
iShares MSCI Eurozone ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents